FDA issues Class II recall of thousands of generic blood pressure tablets

सारांश

The Food and Drug Administration has classified a recall of over 3,700 bottles of generic blood-pressure medication as Class II, citing failed dissolution specifications that could reduce effectiveness.

The U.S. Food and Drug Administration classified a recall of more than 3,700 bottles of generic blood-pressure tablets as Class II on Oct. 26. The recall, initiated by Macleods Pharmaceuticals on Oct. 7, involves products that failed dissolution specifications, meaning the medication may not release its active ingredients at the intended rate inside the body.

The affected tablets contain olmesartan medoxomil, amlodipine and hydrochlorothiazide in a 40 mg/10 mg/12.5 mg formulation. The recall covers 3,528 bottles of the 30-count size (NDC 33342-246-07, lot 12251163A, expiring 05/31/2027) and 216 bottles of the 90-count size (NDC 33342-246-10, lot 12251163B, expiring 05/31/2027).

The FDA’s Class II rating indicates that use of the product could cause temporary or medically reversible adverse health consequences, though serious health issues are unlikely. The agency did not release a news statement; instead, it sent letters to businesses and individuals who may possess the medication.

Consumers who take the generic version of the drug should verify the NDC numbers, lot numbers and expiration dates against the recall list. The brand-name version, Tribenzor, is not included in the recall.

स्रोत

USA Today

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।